The battle between the two front runners in the vast weight loss released top-line results from the SURMOUNT-5 Phase IIIb ...

Despite this escalating demand for popular GLP-1 drugs, the prices for some of these products are actually dropping. Dr.

A new national survey shows that, despite intense marketing, most Americans do not want the new weight-loss injectables, such ...

For the first time in a decade, obesity in the U.S. is declining — and a new study suggests it’s because of wildly popular medications such as Ozempic.

One particular healthcare stock has shown its ability to soar on good news -- and it's had plenty of it. This year the ...

Eli Lilly (LLY) has added a new telehealth partner to expand access to single-dose vials of its blockbuster weight loss drug ...

Despite the skepticism and outrage over Robert F. Kennedy Jr.’s nomination to head the Department of Health and Human ...

Eli Lilly is partnering with the Flatiron-based telehealth company Ro to sell a cheaper version of its popular weight-loss ...

They are currently approved for treating diabetes, obesity and those with a history of cardiovascular disease in people who ...

GLP-1 drugs like Ozempic are injectable medications—but a strange new market has emerged selling oral “compounded” versions online, despite a lack of evidence that they work.